Relmada Therapeutics, Inc. (RLMD)

4.355 -0.48 (-9.83%) USD  |  NASDAQ  |  Jan 02, 16:00
4.28 -0.08 (-1.72%) After-Hours: 20:00
More

Relmada Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
Sensus Healthcare, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade